These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 7507806

  • 1. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
    Schindler R, Marra MN, McKelligon BM, Lonnemann G, Schulzeck P, Schulze M, Oppermann M, Shaldon S.
    Clin Nephrol; 1993 Dec; 40(6):346-51. PubMed ID: 7507806
    [Abstract] [Full Text] [Related]

  • 2. Lipopolysaccharide-binding protein and bactericidal/permeability-increasing factor during hemodialysis: clinical determinants and role of different membranes.
    Sundaram S, King AJ, Pereira BJ.
    J Am Soc Nephrol; 1997 Mar; 8(3):463-70. PubMed ID: 9071715
    [Abstract] [Full Text] [Related]

  • 3. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
    Dentener MA, Von Asmuth EJ, Francot GJ, Marra MN, Buurman WA.
    J Immunol; 1993 Oct 15; 151(8):4258-65. PubMed ID: 8409400
    [Abstract] [Full Text] [Related]

  • 4. Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients.
    Pereira BJ, Sundaram S, Snodgrass B, Hogan P, King AJ.
    J Am Soc Nephrol; 1996 Mar 15; 7(3):479-87. PubMed ID: 8704115
    [Abstract] [Full Text] [Related]

  • 5. [Significance of changes in plasma bactericidal/permeability-increasing protein levels in patients with severe surgical infection].
    Zhang LT, Yao YM, Lu JQ, Yu Y.
    Zhonghua Wai Ke Za Zhi; 2007 Oct 01; 45(19):1342-5. PubMed ID: 18241571
    [Abstract] [Full Text] [Related]

  • 6. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ, van Kessel KP, van den Tol ME, van Strijp JA, Torensma R, Verhoef J, Elsbach P, Weiss J.
    J Immunol; 1993 Jan 01; 150(1):253-63. PubMed ID: 7678030
    [Abstract] [Full Text] [Related]

  • 7. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW.
    J Immunol; 1992 Jan 15; 148(2):532-7. PubMed ID: 1729370
    [Abstract] [Full Text] [Related]

  • 8. The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved.
    Hubacek JA, Büchler C, Aslanidis C, Schmitz G.
    Biochem Biophys Res Commun; 1997 Jul 18; 236(2):427-30. PubMed ID: 9240454
    [Abstract] [Full Text] [Related]

  • 9. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
    Schumann RR, Lamping N, Hoess A.
    J Immunol; 1997 Dec 01; 159(11):5599-605. PubMed ID: 9548502
    [Abstract] [Full Text] [Related]

  • 10. Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein.
    Bülow E, Gullberg U, Olsson I.
    J Leukoc Biol; 2000 Nov 01; 68(5):669-78. PubMed ID: 11073106
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
    Calvano SE, Thompson WA, Marra MN, Coyle SM, de Riesthal HF, Trousdale RK, Barie PS, Scott RW, Moldawer LL, Lowry SF.
    Arch Surg; 1994 Feb 01; 129(2):220-6. PubMed ID: 7508221
    [Abstract] [Full Text] [Related]

  • 13. The BPI/LBP family of proteins: a structural analysis of conserved regions.
    Beamer LJ, Carroll SF, Eisenberg D.
    Protein Sci; 1998 Apr 01; 7(4):906-14. PubMed ID: 9568897
    [Abstract] [Full Text] [Related]

  • 14. Increased bactericidal/permeability increasing protein in patients with cirrhosis.
    Guerra-Ruiz A, Casafont F, Cobo M, Terán A, de-la-Peña J, Estebanez A, Pons-Romero F.
    Liver Int; 2010 Jan 01; 30(1):94-101. PubMed ID: 19765220
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins.
    Amura CR, Kamei T, Ito N, Soares MJ, Morrison DC.
    J Immunol; 1998 Sep 01; 161(5):2552-60. PubMed ID: 9725255
    [Abstract] [Full Text] [Related]

  • 16. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
    Leeuwenberg JF, Dentener MA, Buurman WA.
    J Immunol; 1994 May 15; 152(10):5070-6. PubMed ID: 7513728
    [Abstract] [Full Text] [Related]

  • 17. Molecular cloning and characterization of LPS-binding protein/bactericidal permeability-increasing protein (LBP/BPI) from olive flounder, Paralichthys olivaceus.
    Nam BH, Ahn KJ, Kim YO, Kong HJ, Kim WJ, Kim HS, Lee SJ, Kim KK.
    Vet Immunol Immunopathol; 2010 Feb 15; 133(2-4):256-63. PubMed ID: 19698997
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI).
    Azuma M, Matsuo A, Fujimoto Y, Fukase K, Hazeki K, Hazeki O, Matsumoto M, Seya T.
    Biochem Biophys Res Commun; 2007 Mar 09; 354(2):574-8. PubMed ID: 17239348
    [Abstract] [Full Text] [Related]

  • 19. Plasma levels of myeloperoxidase and elastase are differentially regulated by hemodialysis membranes and anticoagulants.
    Ono K, Ueki K, Inose K, Tsuchida A, Yano S, Nojima Y.
    Res Commun Mol Pathol Pharmacol; 2000 Mar 09; 108(5-6):341-9. PubMed ID: 11958287
    [Abstract] [Full Text] [Related]

  • 20. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
    Muniz-Junqueira MI, Braga Lopes C, Magalhães CA, Schleicher CC, Veiga JP.
    Life Sci; 2005 Nov 04; 77(25):3141-55. PubMed ID: 16005905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.